1RXT |
3.0 |
Crystal structure of human myristoyl-CoA:protein N-myristoyltransferase. |
3IU1 |
1.42 |
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA |
3IU2 |
1.73 |
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD90096 |
3IWE |
1.79 |
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD85646 |
3JTK |
1.61 |
Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD90055 |
4C2Y |
1.64 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA co-factor |
4C2Z |
2.08 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound |
5MU6 |
1.88 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and IMP-1088 inhibitor bound |
5NPQ |
2.372 |
Human N-myristoyltransferase 1 (MNT1) with Myristoyl-CoA analogue X10 bound |
5O6H |
1.29 |
Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-917 |
5O6J |
1.45 |
Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-1031 |
5O9S |
2.7 |
HsNMT1 in complex with CoA and Myristoylated-GKSNSKLK octapeptide |
5O9T |
2.15 |
HsNMT1 in complex with CoA and acetylated-NCFSKPK peptide |
5O9U |
1.85 |
HsNMT1 in complex with CoA and Myristoylated-GCSVSKKK octapeptide |
5O9V |
2.201 |
HsNMT1 in complex with CoA and Myristoylated-GGCFSKPK octapeptide |
5UUT |
2.252 |
N-myristoyltransferase 1 (NMT) bound to myristoyl-CoA |
6EHJ |
2.1 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and peptide bound |
6F56 |
1.9402 |
Mutant of Human N-myristoyltransferase with bound myristoyl-CoA |
6FZ2 |
2.05 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound |
6FZ3 |
2.0 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound |
6FZ5 |
1.89 |
Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound |
6PAV |
2.52 |
Structure of Human NMT1 with products CoA and myristoyl-lysine peptide with acetylated N-terminus |
6QRM |
2.3 |
HsNMT1 in complex with both MyrCoA and GNCFSKRRAA substrates |
6SJZ |
1.995 |
HsNMT1 in complex with both MyrCoA and Acetylated-GNCFSKPR substrates |
6SK2 |
1.90001 |
HsNMT1 in complex with both MyrCoA and Acetylated-GKSFSKPR peptide reveals N-terminal Lysine Myristoylation |
6SK3 |
2.7 |
C-terminal HsNMT1 deltaC3 truncation in complex with both MyrCoA and GNCFSKPR substrates |
6SK8 |
1.87 |
DeltaC3 C-terminal truncation of HsNMT1 in complex with MyrCoA and GDCFSKPR substrates |
6SKJ |
2.8 |
DeltaC2 C-terminal truncation of HsNMT1 in complex with MyrCoA and GNCFSKPR substrates |
7OWM |
1.5 |
HsNMT1 in complex with both MyrCoA and HCPA substrate peptide GKQNSKLR |
7OWN |
2.1 |
HsNMT1 in complex with both MyrCoA and peptide AKSFSKPR |
7OWO |
1.7 |
HsNMT1 in complex with both MyrCoA and N-acetylated KSFSKPR peptide |
7OWP |
1.81 |
HsNMT1 in complex with both MyrCoA and ACE-G-(L-ORN)SFSKPR |
7OWQ |
3.0 |
HsNMT1 in complex with both MyrCoA and peptide N-Methylated-GNCFSKPR |
7OWR |
2.39 |
HsNMT1 in complex with both MyrCoA and peptide GGKSFSKPR |
7OWU |
2.08 |
HsNMT1 in complex with both CoA and Myr-ANCFSKPR peptide |
7RK3 |
2.05 |
Crystal structure of human N-myristoyltransferase 1 fragment (residues 109-496) bound to diacylated human Arf6 octapeptide and Coenzyme A |